• Image of ADZYNMA medication Image of ADZYNMA medication
    • ADZYNMA

ADAMTS13, RECOMBINANT (ADD uhm tee es thur TEEN, ree kom bi nant) treats congenital thrombotic thrombocytopenic purpura (cTTP), a condition that causes blood clots and low levels of platelets in the body. It works by replacing an enzyme normally made by the body. This enzyme helps prevent blood cells from clumping together to form a clot.


ADZYNMA Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.